Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

565 Articles

Chris Lange | Dec 28, 2016 at 10:25 AM EST

Short Interest Rises in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest increased in most of…

Lee Jackson | Dec 27, 2016 at 10:25 AM EST

Jefferies Makes Huge Year-End Addition to Franchise Picks List

A top new addition to the Franchise list portfolio and three additional dividend stocks that the Jefferies team views as…

Chris Lange | Dec 12, 2016 at 8:44 AM EST

Short Sellers Back Way Off Major Pharma Stocks

The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected…

Lee Jackson | Dec 5, 2016 at 10:05 AM EST

Bond Sell-Off Could Be Huge for Stocks: 4 Analyst Top Pick Dividend Stocks to Buy Now

With money expected to come out of the bond market, these four stocks are an attractive alternative that have solid…

Chris Lange | Nov 28, 2016 at 7:15 AM EST

Short Sellers Hike Their Bets in Most Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest was mixed in the…

Lee Jackson | Nov 22, 2016 at 9:40 AM EST

Jefferies Makes Another Huge Addition to Franchise Picks Stocks Portfolio

[cnxvideo id=”506829″ placement=”ros”] With earnings for the third quarter over, and the fourth quarter of 2016 in full swing, many…

Chris Lange | Nov 10, 2016 at 7:40 AM EST

Short Interest Bets Increase on Major Pharma

Drug prices have been under pressure due to the campaign rhetoric, and short interest has increased in most of these…

Lee Jackson | Nov 7, 2016 at 10:05 AM EST

Jefferies Makes a Huge Q4 Change to the Franchise Picks List

In a recent research note, the analysts at Jefferies make a big move by removing a top medical devices company…

Lee Jackson | Nov 1, 2016 at 8:35 AM EDT

Pharma Stocks Crushed Under Election Rhetoric, but Top Analysts Say Buy These 4 Now

The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income…

Jon C. Ogg | Oct 31, 2016 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Chevron, Home Depot, Nike, Qualcomm, VMware and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include AbbVie, Chevron, Home Depot, Nike, Qualcomm and VMware.

Chris Lange | Oct 28, 2016 at 10:05 AM EDT

AbbVie Slides on Top-Line Miss

AbbVie reported mixed third-quarter financial results and a dividend hike before the markets opened on Friday.

Lee Jackson | Oct 28, 2016 at 9:50 AM EDT

Jefferies Adds Top Financial Stock to Franchise Picks Portfolio

Four companies in four very different sectors that all offer liquidity, a degree of safety and solid dividends that should…

Chris Lange | Oct 26, 2016 at 7:40 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Oct 23, 2016 at 10:35 AM EDT

Top Health Care Earnings Coming Next Week

Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of…

Lee Jackson | Oct 13, 2016 at 10:40 AM EDT

Top 5 Jefferies Big Pharma Stock Picks for Q4

A new Jefferies research report features top pharmaceutical picks for the fourth quarter. Any of these top picks make good…

1 … 24 25 26 27 28 … 38

AbbVie : ABBV

All AbbVie Articles

Short Interest Rises in Major Pharma

Jefferies Makes Huge Year-End Addition to Franchise Picks List

Short Sellers Back Way Off Major Pharma Stocks

Bond Sell-Off Could Be Huge for Stocks: 4 Analyst Top Pick Dividend Stocks to Buy Now

Short Sellers Hike Their Bets in Most Major Pharma Stocks

Jefferies Makes Another Huge Addition to Franchise Picks Stocks Portfolio

Short Interest Bets Increase on Major Pharma

Jefferies Makes a Huge Q4 Change to the Franchise Picks List

Pharma Stocks Crushed Under Election Rhetoric, but Top Analysts Say Buy These 4 Now

Top Analyst Upgrades and Downgrades: AbbVie, Chevron, Home Depot, Nike, Qualcomm, VMware and More

AbbVie Slides on Top-Line Miss

Jefferies Adds Top Financial Stock to Franchise Picks Portfolio

Short Sellers Grow More Selective on Major Pharma Stocks

Top Health Care Earnings Coming Next Week

Top 5 Jefferies Big Pharma Stock Picks for Q4

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Fed’s Rate Freeze Could Sting for Social Security Recipients

AbbVie : ABBV

All AbbVie Articles

Short Interest Rises in Major Pharma

Jefferies Makes Huge Year-End Addition to Franchise Picks List

Short Sellers Back Way Off Major Pharma Stocks

Bond Sell-Off Could Be Huge for Stocks: 4 Analyst Top Pick Dividend Stocks to Buy Now

Short Sellers Hike Their Bets in Most Major Pharma Stocks

Jefferies Makes Another Huge Addition to Franchise Picks Stocks Portfolio

Short Interest Bets Increase on Major Pharma

Jefferies Makes a Huge Q4 Change to the Franchise Picks List

Pharma Stocks Crushed Under Election Rhetoric, but Top Analysts Say Buy These 4 Now

Top Analyst Upgrades and Downgrades: AbbVie, Chevron, Home Depot, Nike, Qualcomm, VMware and More

AbbVie Slides on Top-Line Miss

Jefferies Adds Top Financial Stock to Franchise Picks Portfolio

Short Sellers Grow More Selective on Major Pharma Stocks

Top Health Care Earnings Coming Next Week

Top 5 Jefferies Big Pharma Stock Picks for Q4

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s